10-100735739-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001304569.2(PAX2):c.25+6A>T variant causes a splice donor region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000194 in 1,039,148 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00086 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000080 ( 0 hom. )
Consequence
PAX2
NM_001304569.2 splice_donor_region, intron
NM_001304569.2 splice_donor_region, intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.984
Genes affected
PAX2 (HGNC:8616): (paired box 2) PAX2 encodes paired box gene 2, one of many human homologues of the Drosophila melanogaster gene prd. The central feature of this transcription factor gene family is the conserved DNA-binding paired box domain. PAX2 is believed to be a target of transcriptional supression by the tumor suppressor gene WT1. Mutations within PAX2 have been shown to result in optic nerve colobomas and renal hypoplasia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 10-100735739-A-T is Benign according to our data. Variant chr10-100735739-A-T is described in ClinVar as [Likely_benign]. Clinvar id is 3049110.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4_exome allele frequency = 0.00008 (71/887310) while in subpopulation AFR AF= 0.00337 (61/18114). AF 95% confidence interval is 0.00269. There are 0 homozygotes in gnomad4_exome. There are 37 alleles in male gnomad4_exome subpopulation. Median coverage is 29. This position pass quality control queck.
BS2
High AC in GnomAd4 at 131 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAX2 | NM_001304569.2 | c.25+6A>T | splice_donor_region_variant, intron_variant | NP_001291498.1 | ||||
PAX2 | NM_001374303.1 | c.25+6A>T | splice_donor_region_variant, intron_variant | NP_001361232.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAX2 | ENST00000679374.1 | c.25+6A>T | splice_donor_region_variant, intron_variant | ENSP00000506041 | ||||||
PAX2 | ENST00000707078.1 | c.25+6A>T | splice_donor_region_variant, intron_variant | ENSP00000516729 | ||||||
PAX2 | ENST00000553492.5 | n.131+6A>T | splice_donor_region_variant, intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.000863 AC: 131AN: 151718Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
131
AN:
151718
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000800 AC: 71AN: 887310Hom.: 0 Cov.: 29 AF XY: 0.0000903 AC XY: 37AN XY: 409932
GnomAD4 exome
AF:
AC:
71
AN:
887310
Hom.:
Cov.:
29
AF XY:
AC XY:
37
AN XY:
409932
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000863 AC: 131AN: 151838Hom.: 0 Cov.: 33 AF XY: 0.000795 AC XY: 59AN XY: 74244
GnomAD4 genome
AF:
AC:
131
AN:
151838
Hom.:
Cov.:
33
AF XY:
AC XY:
59
AN XY:
74244
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PAX2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 12, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at